We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Early Gene Therapy Data Promising for Sickle Cell Anemia

News   Dec 04, 2018 | Original story from Cincinnati Children's Hospital Medical Center

 
Gene Therapy is Reversing Sickle Cell Anemia Symptoms in Preclinical Trials

Technicians work in the ISO-certified cleanroom laboratory at Cincinnati Children’s where gene-correction therapies are tested and produced for clinical trials like the one for sickle cell anemia presented by Punam Malik MD, at this year’s annual meeting of the American Society of Hematology in San Diego. Image credit: Cincinnati Children's Hospital

 
 
Advertisement
 

RELATED ARTICLES

Red Yeast From Deep-Sea Sediment Shows Anticancer and Antibacterial Properties

News

Scientists have succeeded in demonstrating anticancer and antibacterial effects of red yeast Rhodotorula mucilaginosa, isolated from a deep-sea sediment sample from the Mid-Atlantic Ridge

READ MORE

New Genetic Disorder Discovered That Affects Brain and Craniofacial Skeleton

News

Researchers at the National Institutes of Health have discovered a new genetic disorder characterized by developmental delays and malformations of the brain, heart and facial features.

READ MORE

Key Role for Innate Immunity in Controlling SARS-CoV-2 Viral Load

News

Researchers have developed a mathematical model of SARS-CoV-2 infection that reveals a key role for the innate immune system in controlling viral load.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE